Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 4
2005 3
2006 10
2007 11
2008 17
2009 25
2010 17
2011 15
2012 13
2013 26
2014 22
2015 10
2016 6
2017 9
2018 7
2019 9
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

184 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean yongzhen hu (9 results)?
GSH Activated Biotin-tagged Near-Infrared Probe for Efficient Cancer Imaging.
Guo R, Huang F, Zhang B, Yan Y, Che J, Jin Y, Zhuang Y, Dong R, Li Y, Tan B, Song R, Hu Y, Dong X, Li X, Lin N. Guo R, et al. Among authors: hu y. Theranostics. 2019 May 26;9(12):3515-3525. doi: 10.7150/thno.32742. eCollection 2019. Theranostics. 2019. PMID: 31281494 Free PMC article.
Discovery of 3,4,6-Trisubstituted Piperidine Derivatives as Orally Active, Low hERG Blocking Akt Inhibitors via Conformational Restriction and Structure-Based Design.
Dong X, Zhan W, Zhao M, Che J, Dai X, Wu Y, Xu L, Zhou Y, Zhao Y, Tian T, Cheng G, Jin Z, Li J, Shao Y, He Q, Yang B, Weng Q, Hu Y. Dong X, et al. Among authors: hu y. J Med Chem. 2019 Aug 8;62(15):7264-7288. doi: 10.1021/acs.jmedchem.9b00891. Epub 2019 Jul 24. J Med Chem. 2019. PMID: 31298542
Bis-reaction-trigger as a strategy to improve the selectivity of fluorescent probes.
Li D , Cheng J , Wang CK , Ying H , Hu Y , Han F , Li X . Li D , et al. Among authors: hu y. Chem Commun (Camb). 2018 Jul 19;54(59):8170-8173. doi: 10.1039/c8cc02830c. Chem Commun (Camb). 2018. PMID: 29855640
Novel DPP-4 inhibitors against diabetes.
Liu Y, Hu Y. Liu Y, et al. Among authors: hu y. Future Med Chem. 2014 May;6(7):793-808. doi: 10.4155/fmc.14.39. Future Med Chem. 2014. PMID: 24941873 Review.
Autophagy regulators as potential cancer therapeutic agents: a review.
Li S, Wang L, Hu Y, Sheng R. Li S, et al. Among authors: hu y. Curr Top Med Chem. 2015;15(8):720-44. doi: 10.2174/1568026615666150302105343. Curr Top Med Chem. 2015. PMID: 25732790 Review.
Development of Macrocyclic Peptides Containing Epoxyketone with Oral Availability as Proteasome Inhibitors.
Li D, Zhang X, Ma X, Xu L, Yu J, Gao L, Hu X, Zhang J, Dong X, Li J, Liu T, Zhou Y, Hu Y. Li D, et al. Among authors: hu y. J Med Chem. 2018 Oct 25;61(20):9177-9204. doi: 10.1021/acs.jmedchem.8b00819. Epub 2018 Oct 12. J Med Chem. 2018. PMID: 30265557
Imidazoline derivatives: a patent review (2006--present).
Guan X, Hu Y. Guan X, et al. Among authors: hu y. Expert Opin Ther Pat. 2012 Nov;22(11):1353-65. doi: 10.1517/13543776.2012.727397. Epub 2012 Sep 24. Expert Opin Ther Pat. 2012. PMID: 23003008 Review.
Discovery of (R)-5-((5-(1-methyl-1H-pyrazol-4-yl)-4-(methylamino)pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a novel CHK1 inhibitor for hematologic malignancies.
Tong L, Song P, Jiang K, Xu L, Jin T, Wang P, Hu X, Fang S, Gao A, Zhou Y, Liu T, Li J, Hu Y. Tong L, et al. Among authors: hu y. Eur J Med Chem. 2019 Jul 1;173:44-62. doi: 10.1016/j.ejmech.2019.03.062. Epub 2019 Apr 3. Eur J Med Chem. 2019. PMID: 30986571
184 results
Jump to page
Feedback